Genentech Gets Taiwanese Co. To Abandon Biosimilars

Law360 (September 9, 2019, 4:04 PM EDT) -- Taiwan's JHL Biotech has agreed to stop developing copycat versions of four Genentech biologics as part of an unfinalized deal to end high-stakes trade secrets litigation, Genentech confirmed Monday. 

Genentech Inc. said it's reached a memorandum of understanding with JHL Biotech Inc., with a formal settlement deal to come out "in due course." The two companies have been battling in court since October 2018, when a former top Genentech scientist and three of her former coworkers were charged with stealing medical formulas and other trade secrets to give to JHL, with civil litigation quickly following.

The memorandum of understanding requires JHL to "abandon...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS